Skip to content
Screener

AbbVie ABBV Cash Flow Statement

Q2 '26Q1 '26Q4 '25Q3 '25Q2 '25
$3.62B+284%$697M-45.9%$1.82B$188M-88.0%$941M-31.5%
$444M+8.3%$157M-4.3%$209M+15.5%$179M-17.9%
$3.83B+134%$5.22B-26.0%$7.02B+29.0%$5.15B+127%
$265M+12.8%$329M+13.1%$381M+53.0%$269M+11.6%
$0-100%
-$574M+21.9%-$1.46B+21.9%-$3.26B+60.5%-$1.18B-7.2%
$3.09B+5.5%$2.91B+5.8%$2.91B+5.8%$2.91B+5.8%
$1.49B+54.9%$3M-99.2%$4M-76.5%$12M+33.3%
$7.99B+100%
$919M+173%-$4.17B+39.3%-$4.59B-$2.71B
$4.16B+1,293%-$400M+76.9%-$838M+85.7%$1.29B+126%

FAQ

Where does AbbVie's cash flow data come from?
Every line is extracted from AbbVie's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.